Authors/Disclosures
Adriano Chio, MD, FAAN
(Dept. of Neuroscience, University of Turin)
|
Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cytokinetics. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Corcept. |
David G. Vossler, MD, FAAN
(David G. Vossler MD FAAN FAES FACNS)
|
Dr. Vossler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biocodex Pharmaceuticals. Dr. Vossler has received personal compensation in the range of $0-$499 for serving as a Consultant for Biohaven Pharmaceuticals. Dr. Vossler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Longboard Pharmaceuticals. Dr. Vossler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Xenon Pharmaceuticals. Dr. Vossler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Science. The institution of Dr. Vossler has received research support from SK Life Science. The institution of Dr. Vossler has received research support from Xenon Pharmaceuticals. The institution of Dr. Vossler has received research support from Longboard Pharmaceuticals. |
|
No disclosure on file |
Maura Brunetti
|
No disclosure on file |
|
No disclosure on file |
Andrea Calvo, MD, PhD, FAAN
(Dept. of Neuroscience, University of Turin)
|
Dr. Calvo has nothing to disclose. |
Cristina Moglia
(University of Torino)
|
Cristina Moglia has nothing to disclose. |
Bryan Traynor, MD
(National Institute on Aging)
|
The institution of Dr. Traynor has received research support from ALS Association. The institution of Dr. Traynor has received research support from Merck. The institution of Dr. Traynor has received research support from Myasthenia Gravis Foundation. The institution of Dr. Traynor has received research support from Cerevel Therapeutics. Dr. Traynor has received intellectual property interests from a discovery or technology relating to health care. |
|
No disclosure on file |
|
No disclosure on file |
|
No disclosure on file |
Sandra D'Alfonso
|
No disclosure on file |
Gabriele Mora, MD
|
Dr. Mora has nothing to disclose. |
Letizia Mazzini
|
No disclosure on file |
|
No disclosure on file |